BCRX icon

BioCryst Pharmaceuticals

109 hedge funds and large institutions have $156M invested in BioCryst Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$167K
Puts
$92K
Net Calls
Net Calls Change

Top Buyers

1 +$13.3M
2 +$4.21M
3 +$2.24M
4
VM
VHCP Management
New York
+$1.59M
5
SIM
Spark Investment Management
New York
+$1.25M

Top Sellers

1 -$18.4M
2 -$16.9M
3 -$14M
4
Invesco
Invesco
Georgia
-$11.4M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.74M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$817K
27
$745K
28
$740K
29
$686K
30
$570K
31
$510K
32
$453K
33
$435K
34
$423K
35
$385K
36
$366K
37
$355K
38
$353K
39
$337K
40
$335K
41
$303K
42
$293K
43
$283K
44
$263K
45
$244K
46
$242K
47
$238K
48
$233K
49
$206K
50
$196K